Clara Cortell-Fuster

ORCID: 0000-0003-0192-0629
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Histiocytic Disorders and Treatments
  • Tuberous Sclerosis Complex Research
  • Tumors and Oncological Cases
  • Vascular Tumors and Angiosarcomas
  • Pressure Ulcer Prevention and Management
  • Surgical site infection prevention
  • Cancer and Skin Lesions
  • Wound Healing and Treatments
  • Polyomavirus and related diseases

Hospital Universitario Doctor Peset
2019-2025

Topical rapamycin is the pharmacological treatment of choice for facial angiofibromas in rare tuberous sclerosis disease. A new, more advanced, and complex formula was developed our pharmacy service: 0.4% liposomal formulation, with better organoleptic characteristics a favorable release profile active ingredient. The purpose this study to evaluate effectiveness safety topical injuries This an observational, prospective, multicenter study. Effectiveness evaluated mainly through Facial...

10.1016/j.farma.2024.08.005 article EN cc-by-nc-nd Farmacia Hospitalaria 2025-02-01

Abstract Introduction Topical rapamycin has been established as an effective and safe therapy for facial angiofibromas in tuberous sclerosis. Different formulations have tested this skin disease, most using ointment a vehicle. Purpose To improve the classical formulation of topical to determine validity period proposed options based on chemical, physical, microbiological stability studies. Methods Four different 0.4% were prepared (ointment, emulsion, gel, liposomes). The studies each over...

10.1007/s12247-023-09792-9 article EN cc-by Journal of Pharmaceutical Innovation 2023-12-01

Topical rapamycin is the pharmacological treatment of choice for facial angiofibromas in rare tuberous sclerosis disease. A new, more advanced, and complex formula was developed our pharmacy service: 0.4% liposomal formulation, with better organoleptic characteristics a favorable release profile active ingredient. The purpose this study to evaluate effectiveness safety topical injuries This an observational, prospective, multicenter study. Effectiveness evaluated mainly through severity...

10.1016/j.farma.2024.04.023 article ES cc-by-nc-nd Farmacia Hospitalaria 2024-06-01

Introduction: topical rapamycin has been established as an effective and safe therapy for facial angiofibromas in tuberous sclerosis. Different formulations have tested this skin disease, most using ointment a vehicle. Purpose: to improve the classical formulation of determine validity period proposed options based on chemical, physical microbiological stability studies. Methods: four different 0.4% were prepared (ointment, emulsion, gel liposomes). The studies each were: chemical...

10.22541/au.165397327.71487839/v1 preprint EN Authorea (Authorea) 2022-05-31
Coming Soon ...